Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 701–800 of 942
Sukumaran, D. K., Garcia, E., Hua, J., Tabaczynski, W. A., Odunsi, K. O., Andrews, C., & Szyperski, T. (2009) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.2469 · Cited by 16
Composition and Function of the Gut Microbiome
Blaut, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_2 · Cited by 33
Chilloux, J., Brial, F., Everard, A., Smyth, D. R., Andrikopoulos, P., Zhang, L., Plovier, H., Myridakis, A., Hoyles, L., Moreno‐Navarrete, J. M., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01413-8 · Cited by 26
“These results depict an increased microbial conversion of choline into TMA in our HC-HFD, an observation already made in a previous study 13 .”
InfluentialSelf-citationSingh, S., Kriti, M., Catanzaro, R., Marotta, F., Malvi, M., Jain, A. K., Verma, V., Nagpal, R., Tiwari, R. R., & Kumar, M. (2024) · Livers · doi:10.3390/livers4030032 · Cited by 17
Mei, H., Li, J., Liu, S., Jeyaraj, A., Zhuang, J., Wang, Y., Chen, X., Yuan, Q., & Li, X. (2023) · Foods · doi:10.3390/foods12152953 · Cited by 17
“Additionally, gut microbiota may play an active role in insulin resistance development [10].”
BackgroundGut Microbial Signatures of Distinct Trimethylamine N-Oxide Response to Raspberry Consumption
Franck, M., de Toro‐Martín, J., Varin, T. V., Garneau, V., Pilon, G., Roy, D., Couture, P., Couillard, C., Marette, A., & Vohl, M. (2022) · Nutrients · doi:10.3390/nu14081656 · Cited by 16
“In this regard, switching mice with NASH from a low-fat diet to a Western diet resulted in changes in the gut microbial ecology towards a higher metabolism and conversion of choline to methylamines [28].”
BackgroundIntestinal microbiota-farnesoid X receptor axis in metabolic diseases
Zou, B., Yang, W., Tang, Y., Hou, Y., Tang, T., & Qu, S.-L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.006 · Cited by 15
Isacco, C. G., Ballini, A., Vito, D. D., Inchingolo, A. M., Cantore, S., Paduanelli, G., Nguyen, K. C. D., Inchingolo, A. D., Dipalma, G., & Inchingolo, F. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88601 · Cited by 17
Homocysteine supplementation ameliorates steatohepatitis induced by a choline‐deficient diet in mice
Minami, S., Miura, K., Ishioka, M., Morimoto, N., Isoda, N., Yamamoto, H., & Iijima, K. (2018) · Hepatology Research · doi:10.1111/hepr.13234 · Cited by 17
Microbiota intestinal en la salud y la enfermedad
Icaza-Chávez, M. E. (2013) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2013.04.004 · Cited by 91
Metabolic phenotyping and systems biology approaches to understanding neurological disorders
Dumas, M., & Davidovic, L. (2013) · F1000Prime Reports · doi:10.12703/p5-18 · Cited by 15
“insulin resistance-associated non-alcoholic fatty liver disease [8], diabetes [9,10], hypertension [11] or coronary artery diseases [12].”
BackgroundSelf-citationThe Pathophysiology of Portal Hypertension
Ramkissoon, R. A., Cao, S., & Shah, V. H. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.03.001 · Cited by 23
He, Y., Xu, M., Lü, S., Zou, W., Wang, Y., Kulyar, M. F., Iqbal, M., & Li, K. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106159 · Cited by 16
Zhou, Q., Qu, Z., Wang, N., Liu, H., Hongmei, Y., & Wang, H. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.3136 · Cited by 15
“At the same time, some Bacteroidetes can also regulate lipid metabolism disorders induced by a HFD (Dumas et al., 2006).”
BackgroundChen, C., Xu, C., Yang, X., Jia, Y., Gu, Z., & Li, E. (2022) · Aquaculture Nutrition · doi:10.1155/2022/2640479 · Cited by 18
“The gut bacterial community participates in a variety of physiological metabolic activities, such as lipid storage, energy balancing, and bile acid synthesis [14].”
BackgroundKuang, L., Zhou, W. L., & Jiang, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260479 · Cited by 15
Zhang, P., Wang, S., He, Y., Xu, Y., Shi, D., Yang, F., Yu, W., Zhu, W., & He, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215457 · Cited by 15
“Methylamines can be derived from dietary choline, which break down to MA, DMA, and TMA by gut microflora [30].”
BackgroundPlaza, A., Antonazzi, M., Blanco‐Urgoiti, J., Olmo, N. D., & Ruiz‐Gayo, M. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900110 · Cited by 13
Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing
Guo, Y., Hwang, L., Li, J., Eades, J., Yu, C. W., Mansfield, C. J., Burdick-Will, A., Chang, X., Chen, Y., Duke, F. F., et al. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0369-8 · Cited by 16
“If these particular bacteria are present in high levels, they can deprive the person of choline needed for other metabolic pathways [48].”
BackgroundTreatment of insulin resistance: straight from the gut
Zhang, X., Zheng, X., & Yuan, Y. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.016 · Cited by 13
Kadar, H., Dubus, J., Dutot, J., Hedjazi, L., Srinivasa, S., Fitch, K. V., Grinspoon, S. K., Nicholson, J. K., Dumas, M., & Gauguier, D. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.03.029 · Cited by 15
Self-citationGenomics, Proteomics, and Metabolomics in Nutraceuticals and Functional Foods
Bagchi, D., Lau, F., & Bagchi, M. (2010) · Wiley eBooks · doi:10.1002/9780813821474 · Cited by 20
Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs
Jänis, M. T., Laaksonen, R., & Orešič, M. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.6.665 · Cited by 15
“For example, it was recently shown that metabolism of an essential micronutrient, choline, depends on the composition of intestinal microbiota [8].”
BackgroundMetabonomics and diabetes mellitus
Chen, P., & Liu, J.-C. (2007) · Advances in Therapy · doi:10.1007/bf02877709 · Cited by 13
Application of quantitative metabolomics in systems genetics in rodent models of complex phenotypes
Gauguier, D. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.09.016 · Cited by 15
Self-citationKoutsos, A., & Lovegrove, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407825-3.00012-5 · Cited by 22
Alam, N., Jia, L., Cheng, A., Ren, H., Fu, Y., Ding, X., Haq, I. U., & Liu, E. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1390483 · Cited by 14
Gabr, M. T., & Świderek, K. (2020) · ChemMedChem · doi:10.1002/cmdc.202000571 · Cited by 15
Dall’Oglio, F., Milani, M., & Micali, G. (2018) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s179627 · Cited by 19
“13 Larsen et al 14 have shown that gut microbiota in type 2 diabetic subjects differs from nondiabetic adults.”
Fabian, E., Bordag, N., Herold, M., Kamp, H., Krennrich, G., Looser, R., Ma-Hock, L., Mellert, W., Montoya, G., Peter, E., et al. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.05.003 · Cited by 12
Trimethylamine—The Extracorporeal Envoy
Mitchell, S. C., & Smith, R. L. (2016) · Chemical Senses · doi:10.1093/chemse/bjw001 · Cited by 15
Self-citationWang, J., Yue, H., Xia, Z. Q., Wu, S., Zhang, H. J., Ji, F., Xu, L., & Qi, G. (2012) · Poultry Science · doi:10.3382/ps.2011-02074 · Cited by 13
“The ability to convert TMA to TMAO by FMO3 may be abolished or diminished by the mutation of T329S in hens (Honkatukia et al., 2005; Ward et al., 2009).”
BackgroundInfluentialCholine deprivation: An overview of the major hepatic metabolic response pathways
Al‐Humadi, H., Ζάρρος, Α., Kyriakaki, A., Al‐Saigh, R., & Liapi, C. A. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.685755 · Cited by 14
“In healthy individuals, elevated lipid concentrations in the liver lead to increased VLDL production and secretion, whereas the impairments in lipid export via VLDL secretion, b-oxidation of FFA, or other metabolic pathways observed in patients with NAFLD result in an inability to maintain fat balance and prevent fatt…”
BackgroundInfluentialTong, X., Sun, H., Yan, G.-L., Dong, W., Sun, W.-J., Yu, Y., Wang, P., Han, Y., & Wang, X.-J. (2011) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-011-0728-9 · Cited by 12
A Grand Challenge for Nutrigenomics
Zeisel, S. H. (2010) · Frontiers in Genetics · doi:10.3389/fgene.2010.00002 · Cited by 11
Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage
Aubel, I., & Bertau, M. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003769859 · Cited by 9
“Numerous studies have been published which take advantage of gnotobiotic models for example on metabolic endotoxemia-induced inflammation [39] or with genetically changed organisms such as insulin-resistant mice [75].”
BackgroundZeng, M., Xiao, Y., Liang, Y., Wang, B., Chen, X., Cao, D., Li, H., Wang, M., & Zhou, Z. (2010) · Metabolomics · doi:10.1007/s11306-009-0193-z · Cited by 13
“Metabolic profiling, a useful technique for understanding the metabolic alterations of exogenous or endogenous stimuli, has proved to be a powerful tool for understanding the mechanism of diseases (Webb et al. 2000; Dumas et al. 2006), and it may find further applications in IFG.”
BackgroundMethodThe Human Microbiome and Infectious Diseases: Beyond Koch
Young, V. B., Britton, R. A., & Schmidt, T. M. (2008) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2008/296873 · Cited by 17
Moco, S., & Ross, A. B. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_5 · Cited by 15
Flint, H. J., Duncan, S. H., & Louis, P. (2009) · Elsevier eBooks · doi:10.1533/9781845696603.1.38 · Cited by 5
Exploiting the Potential of Metabonomics in Large Population Studies: Three Venues
Singer, B. H., Utzinger, J., Ryff, C. D., Wang, Y., & Holmes, E. C. (2007) · Elsevier eBooks · doi:10.1016/b978-044452841-4/50012-6 · Cited by 12
Self-citationKandalgaonkar, M. R., Kumar, V., & Vijay–Kumar, M. (2024) · Physiological Reports · doi:10.14814/phy2.16114 · Cited by 12
Beiriger, J., Chauhan, K., Khan, A., Shahzad, T., Parra, N. S., Zhang, P. G. Y., Chen, S., Nguyen, T. A., Yan, B. M., Bruckbauer, J., et al. (2023) · Livers · doi:10.3390/livers3040042 · Cited by 17
A benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiota
Gabr, M. T., Machalz, D., Pach, S., & Wolber, G. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00218f · Cited by 15
Brial, F., Lay, A. L., Hedjazi, L., Tsang, T. M., Fearnside, J., Otto, G., Alzaïd, F., Wilder, S. P., Venteclef, N., Cazier, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40153-0 · Cited by 13
Self-citationWang, D., Wang, X., Zhang, P., Wang, Y., Zhang, R., Yan, J., Zhou, Z., & Zhu, W. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.11.028 · Cited by 14
“TMA is the first metabolite of choline from microorganisms, and accumulation of TMA was reported to cause hepatic toxicity to mammals (Dumas et al., 2006).”
BackgroundThe Microbiome and the Liver: The Basics
Victor, D., & Quigley, E. (2016) · Seminars in liver disease (Print) · doi:10.1055/s-0036-1593879 · Cited by 11
The microbiota as an epigenetic control mechanism
Ba, S. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch11 · Cited by 12
1H NMR Metabolic Profiling of Plasma Reveals Additional Phenotypes in Knockout Mouse Models
Probert, F., Rice, P., Scudamore, C. L., Wells, S. E., Williams, R. L., Hough, T., & Cox, I. J. (2015) · Journal of Proteome Research · doi:10.1021/pr501039k · Cited by 11
Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.
Solga, S. F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.9017 · Cited by 15
Monitoring Healthy Metabolic Trajectories with Nutritional Metabonomics
Collino, S., Martin, F., Kochhar, S., & Rezzi, S. (2009) · Nutrients · doi:10.3390/nu1010101 · Cited by 14
“Recent findings highlighted the gut microbiota as a key determinant in the etiology of many disease, including insulin resistance [30], obesity [31,32], food allergies [33], gastritis and peptide ulcers [34,35]”
BackgroundThe gut microbiota and disease – an inner repository for drug discovery
Shanahan, F., & Kiely, B. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.02.006 · Cited by 12
Pathogenesis of NAFLD and NASH
Maher, J. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_4 · Cited by 10
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link
Effenberger, M., Grander, C., Grabherr, F., & Tilg, H. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00069 · Cited by 17
“114 However, other studies reported that dietary intake of choline and phosphatidylcholine were associated with increased TMA and TMAO production.”
BackgroundInfluentialHepatocellular carcinoma and microbiota: Implications for clinical management and treatment
Spanu, D., Pretta, A., Lai, E., Persano, M., Donisi, C., Mariani, S., Dubois, M., Migliari, M., Saba, G., Ziranu, P., et al. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i7.1319 · Cited by 17
Zhou, J., Ji, P.-C., Jiang, H., Tan, X., & Jia, A. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.830632 · Cited by 13
Ganesan, R., Vasantha‐Srinivasan, P., Sadhasivam, D. R., Subramanian, R., Vimalraj, S., & Suk, K. T. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.688827 · Cited by 18
Li, J. V., Swann, J. R., & Marchesi, J. R. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.006 · Cited by 14
Li, J. V., Saric, J., Yap, I. K. S., Utzinger, J., & Holmes, E. C. (2013) · Molecular BioSystems · doi:10.1039/c3mb70215d · Cited by 11
Self-citationImportance and Roles of Fiber in the Diet
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7_7 · Cited by 18
Li, W., Dong, H., Niu, K., Wang, H., Cheng, W., Song, H. L., Ying, A., Zhai, X., Li, K., Yu, H., et al. (2024) · Talanta · doi:10.1016/j.talanta.2024.126480 · Cited by 12
Oh, J., Kim, J., Lee, S., Park, G., Baritugo, K., Han, K. J., Lee, S., & Sung, G. (2024) · Metabolites · doi:10.3390/metabo14010039 · Cited by 11
“Thus, TMAO is considered as an important biomarker and a new therapeutic target for many associated diseases [6,18–20].”
BackgroundHu, L., Brito, L. F., Luo, H., Chen, S., Johnson, J. S., Sammad, A., Guo, G., Xu, Q., & Wang, Y. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00043 · Cited by 11
Angamuthu, S., Ramaswamy, C. R., Selvankumar, T., Sadhasivam, D. R., Nallaswamy, V. D., Subramanian, R., Ganesan, R., & Raju, A. (2021) · Process Biochemistry · doi:10.1016/j.procbio.2021.05.024 · Cited by 10
1-(4-Amino-2-Hydroxyphenyl)Ethenone Suppresses Agrobacterium tumefaciens Virulence and Metabolism
Zhou, J., Jia, A., Tan, X., Chen, H., Bing, S., Huang, T., He, Y., Li, P., & Liu, E. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.584767 · Cited by 12
Abramowicz, K., Krauze, M., & Ognik, K. (2020) · Animal Production Science · doi:10.1071/an18737 · Cited by 9
Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease
Ахмедов, В. А., & Gaus, O. V. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.02.000051 · Cited by 13
“Высокая метаболическая активность данных бактерий может приводить к дефициту холина и, как следствие, фосфатидилхолина в организме хозяина, что, в свою очередь, повышает риск развития стеатоза печени [15].”
Intestinal microbiota and its relationship with diabetes and obesity
Pokrzywnicka, P., & Gumprecht, J. (2017) · Clinical Diabetology · doi:10.5603/dk.2016.0029 · Cited by 16
“It can also initiate lipid peroxidation in the host organism [45].”
BackgroundEffect of the Gut Microbiota on Obesity and Its Underlying Mechanisms: an Update.
Qian, L., Li, H. T., Zhang, L., Fang, Q., & Jia, W. (2015) · Biomedical and environmental sciences : BES · doi:10.3967/bes2015.117 · Cited by 9
Altered expression and function of hepatic natural killer T cells in obese and diabetic KK‐Ay mice
Yamagata, H., Ikejima, K., Takeda, K., Aoyama, T., Kon, K., Okumura, K., & Watanabe, S. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01062.x · Cited by 10
Gut microbiota and bile acids: An old story revisited (again)
Pean, N., Doignon, I., & Tordjmann, T. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.06.006 · Cited by 9
Simmons-Boyce, J. L., Purcell, S. L., Nelson, C. M., & MacKinnon, S. L. (2009) · Journal of Nutrition · doi:10.3945/jn.109.107920 · Cited by 12
“Experiments show that germfree mice do not excrete TMA or TMAO, indicating that methylamines are direct products of gut microflora metabolism (35).”
Gut Microbiota and Metabolic Diseases: From Pathogenesis to Therapeutic Perspective
Burcelin, R., Courtney, M., & Amar, J. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_11 · Cited by 9
Bengmark, S. (2014) · ASM Press eBooks · doi:10.1128/9781555815462.ch24 · Cited by 12
Metabolic biomarkers in irritable bowel syndrome diagnosis
Vakili, O., Sedeh, P. A., & Pourfarzam, M. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119753 · Cited by 12
Diet dependent impact of benzoate on diabetes and obesity in mice
Brial, F., Matsuda, F., & Gauguier, D. (2021) · Biochimie · doi:10.1016/j.biochi.2021.12.010 · Cited by 8
Self-citationLees, H., Swann, J. R., Poucher, S. M., Holmes, E. C., Wilson, I. D., & Nicholson, J. K. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00040 · Cited by 8
Self-citationChen, J., Zhang, J., Wu, X., Chen, J., Dai, Y., Ma, X., Yu, Y., Zhang, L., & Liu, C. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00782 · Cited by 11
Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions
Chen, E. B., Cason, C. A., Gilbert, J. A., & Ho, K. J. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3755-4 · Cited by 7
Non Alcoholic Fatty Liver Overview
Debes, M. S. (2015) · Journal of Liver · doi:10.4172/2167-0889.1000177 · Cited by 7
“The underlying mechanism could be attributed to an inflammatory process, as these microbes/microbe products - in case of incompetent tight junctions of small intestinal mucosal cells - could gain access to the portal circulation ,and drive an inflammatory process contributing to insulin resistance and hepatic fat depo…”
BackgroundBrain and liver fatty acid composition changes upon consumption ofLactobacillus rhamnosusLA68
Ivanović, N., Minić, R., Djuricic, I. D., Dimitrijević, L., Sobajic, S. S., Zivkovic, I. P., & Djordjevic, B. I. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.979313 · Cited by 11
“, 2004) and contributes to a fatty liver phenotype in insulin-resistant mice (Dumas et al., 2006).”
BackgroundNutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions
Mine, Y., Miyashita, K., & Shahidi, F. (2009) · Wiley eBooks · doi:10.1002/9780813807263 · Cited by 22
The potential role of the intestinal gut microbiota in obesity and the metabolic syndrome
Fava, F., Lovegrove, J. A., Tuohy, K. M., & Gibson, G. R. (2009) · Food Science & Technology Bulletin Functional Foods · doi:10.1616/1476-2137.15557 · Cited by 7
Acclimatisation-induced stress influenced host metabolic and gut microbial composition change
Yap, I. K. S., Kho, M. T., Lim, S. E., Ismail, N. H., Yam, W. K., & Chong, C. W. (2014) · Molecular BioSystems · doi:10.1039/c4mb00463a · Cited by 5
Advances in Technologies and Study Design
Parnell, L. D. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398397-8.00002-2 · Cited by 5
Bolat, E., Canbolat, A. A., Sarıtaş, S., Lombardo, M., Witkowska, A. M., El-Seedi, H. R., Bechelany, M., & Karav, S. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71645 · Cited by 10
Zheng, J., Wang, C., Teng, M., Li, T., Jiang, J., Chen, X., & Wu, F. (2026) · Aquatic Toxicology · doi:10.1016/j.aquatox.2026.107713 · Cited by 7
Wu, W., Cheng, J., Hou, Z., Yan, Q., Wang, X., He, J., Zhu, Y., & Li, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01846-x · Cited by 8
“Fiber, a key beneficial dietary component included in DI-GM, has been shown to enhance gut microbes that metabolize choline, thereby reducing its bioavailability and generating metabolites such as trimethylamine [59, 60].”
The liver-gut axis perspective: Exploring the pathogenesis of fatty liver
Yang, Z., Zhang, J., Liu, X., Chen, H., Duan, H., Wang, Q., Zhao, W., & Jin, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177822 · Cited by 8
Kashyap, B., Hyvärinen, E., Laitinen, I., & Kullaa, A. M. (2024) · Clinical Oral Investigations · doi:10.1007/s00784-023-05389-1 · Cited by 11
“The changes in the metabolic profile of the biofluids in a variety of physiological and pathological processes signal the presence of a disease state [9].”
BackgroundCai, H., Li, D., Song, L., Xu, X., Han, Y., Meng, K., Wen, Z., & Yang, P. (2022) · Foods · doi:10.3390/foods11162491 · Cited by 9
“The result indicated that FRT10 intervention pro- motes choline metabolism, which is in agreement with the fact that reduced choline bioa- vailability may lead to NAFLD [29,30].”
ResultHost—microbial interactions in metabolic diseases: from diet to immunity
Lee, J.-H., & Park, J. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-2087-y · Cited by 7
“Moreover, TMAO increases the risk of thrombosis by causing platelet hyperreactivity (Zhu et al., 2016), and has been implicated in fatty liver disease (Dumas et al., 2006).”
BackgroundNeuroendocrine Neoplasms: Identification of Novel Metabolic Circuits of Potential Diagnostic Utility
Jiménez, B., Mei Ran Abellona, U., Drymousis, P., Kyriakides, M., Clift, A. K., Liu, D., Rees, E., Holmes, E. C., Nicholson, J. K., Kinross, J. K., et al. (2021) · Cancers · doi:10.3390/cancers13030374 · Cited by 11
“TMA is further metabolised into TMAO by flavin monooxygenases in the liver [47].”
BackgroundSelf-citationBarbuti, R. C., Schiavon, L. D. L., de Oliveira, C. P. M. S., Álvares‐da‐Silva, M. R., Sassaki, L. Y., Passos, M. D. C. F., Farias, A. Q., Barros, L. L., Barreto, B. A. P., de Albuquerque, G. B. D. M. L., et al. (2020) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202000000-72 · Cited by 26
“The increase in the production of this compound leads to a decrease in the export of hepatic VLDL and modulation of bile acid synthesis, with detrimental effects to the liver, such as increased liver fat deposition, inflammatory and oxidative lesions, and decreased glucose metabolism(90).”
BackgroundChilloux, J., Brial, F., Everard, A., Smyth, D. R., Andrikopoulos, P., Zhang, L., Plovier, H., Myridakis, A., Hoyles, L., Moreno‐Navarrete, J. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/277434 · Cited by 3
Self-citationLibiger, O., & Schork, N. J. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00350 · Cited by 8
System responses to chronic cold stress probed via 1H NMR spectroscopy in plasma and urine matrices
Yang, Y., Wang, Y., Zhang, J., Han, Z., Chen, A., Pan, S., Liang, S., & Wang, S. (2015) · Molecular BioSystems · doi:10.1039/c5mb00033e · Cited by 9
New food safety concerns associated with gut microbiota
Xu, X., He, S., & Zhang, X. (2013) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2013.07.007 · Cited by 9
Gut Microbiota, Obesity and Metabolic Dysfunction
Meiliana, A., & Wijaya, A. (2011) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v3i3.147 · Cited by 9
Genome-Based Nutrition in Chronic Liver Disease
Román, S., Rivera‐Íñiguez, I., Ojeda‐Granados, C., Sepúlveda-Villegas, M., & Panduro, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00001-x · Cited by 7
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.